Shuttle Pharmaceuticals Holdings,Inc. SHPH 深 滬
等待開盤 10-27 09:30:00 美东时间
3.07
-0.020
-0.65%
華盛通- 最 高3.1876
- 今 開3.15
- 成交量 3.50万股
- 最 低 3.01
- 昨 收 3.09
- 總市值 328.74万
- 52周最高 43.50
- 市盈率 靜 --
- 換手率 3.27%
- 52周最低 3.00
- 委 比 -42.47%
- 總股本 107.08万
- 歷史最高 25252.00
- 量 比 0.09
- 振 幅 5.75%
- 歷史最低 3.01
- 每 手 1
- 風險率 9.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Shuttle Pharmaceuticals Holdings shares are trading higher after the company announced it will acquire Molecule's assets and liabilities for $10 million.
Shuttle Pharmaceuticals Holdings shares are trading higher after the company an...
10-22 04:13
Shuttle Executes LOI with Molecule.ai
Shuttle Pharmaceuticals has signed a non-binding letter of intent to acquire Molecule.ai, an AI company founded by Dr. ZT Zhang, to accelerate drug discovery. Molecule.ai's platform uses advanced machine learning models to evaluate molecules efficiently and accurately. Key features include property prediction, drug-target interaction modeling, and autonomous AI workflows. Shuttle will pay $10 million in cash and shares, contingent on milestones, ...
10-10 14:20
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Aditxt (NASDAQ:ADTX) shares increased by 28.3% to $0.89 during Thursda...
10-10 05:06
Shuttle to enter AI pharmaceutical market
Shuttle Pharmaceuticals (NASDAQ:SHPH) announced on Thursday the execution of a non-binding letter of intent with Molecule.ai. Molecule.ai, an artificial intelligence company founded by AI scientist an...
10-10 04:27
Shuttle Pharmaceuticals Announces Non-Binding LOI To Purchase Molecule.ai For $10M
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of
10-10 04:19
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
Shuttle Pharmaceuticals has signed a non-binding letter of intent to acquire Molecule.ai, an AI company founded by Dr. ZT Zhang that specializes in drug discovery. The acquisition aims to leverage Molecule.ai’s advanced AI platform, which uses machine learning models to improve the accuracy and efficiency of evaluating novel molecules, reducing development timelines and costs. The platform includes features like molecule property prediction, drug...
10-09 20:15
Shuttle Pharmaceuticals Signs Consulting Agreement with IR Agency
An update from Shuttle Pharmaceuticals Holdings, Inc. ( ($SHPH) ) is now availa...
09-23 05:32
Shuttle Pharmaceuticals Director Joseph Tung Resigns
An update from Shuttle Pharmaceuticals Holdings, Inc. ( ($SHPH) ) is now availa...
09-18 04:49
Shuttle Pharmaceuticals Appoints Adam Chambers as Director
Shuttle Pharmaceuticals Holdings, Inc. ( ($SHPH) ) just unveiled an announcemen...
09-09 05:30
Shuttle Pharmaceuticals Director Steven Richards Resigns
Shuttle Pharmaceuticals Holdings, Inc. ( ($SHPH) ) has issued an update. On Aug...
09-06 05:00
